top of page

AER20 Panel: Clarifying the Myths and Challenging Bias About Race in Research Review

Updated: Dec 15, 2022

The research enterprise has a distinct obligation to grapple with systemic racism, given its historical abuses of communities of color. The ethics framework governing research with human subjects was created in direct response to the exploitation of Black men in the US Public Health Service Syphilis Study at Tuskegee. This history, alongside inequities in employment, wealth, education, and housing, and the chronic devaluing of lives of people of color, has persistently undermined the health of these populations. Despite efforts to earn the trust of these communities, address racial biases in research, and increase the representation of people of color among research participants and beneficiaries, there is much more work to be done. How can HRPP/IRB professionals and researchers work to dismantle racism as it manifests in research? This panel will explore several levers for effecting change, including identifying and addressing bias within institutions conducting research, challenging myths and assumptions about communities of color, engaging in community participatory research, and ensuring equitable access to research results.


Watch Here:




 
 
 

Recent Posts

See All
NCI-2025-06021

Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer (TRIPL) This is a research study exploring how combining radiation therapy with dual immune check

 
 
 
NCI-2024-05588

A Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants with Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in the AdjuvanT Setting (INSIGHT) The INSI

 
 
 
NCI-2022-08569

Randomized Phase III Trial of mFOLFIRINOX /- Nivolumab vs. FOLFOX /- Nivolumab for First-Line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma This randomized Phase III research

 
 
 

Comments


bottom of page